RRMGX
Price
$88.01
Change
-$3.05 (-3.35%)
Updated
Dec 18 closing price
SPYGX
Price
$20.19
Change
-$1.12 (-5.26%)
Updated
Dec 18 closing price
Ad is loading...

RRMGX vs SPYGX

Header iconRRMGX vs SPYGX Comparison
Open Charts RRMGX vs SPYGXBanner chart's image
T. Rowe Price Mid-Cap Growth R
Price$88.01
Change-$3.05 (-3.35%)
VolumeN/A
CapitalizationN/A
Spyglass Growth Institutional
Price$20.19
Change-$1.12 (-5.26%)
VolumeN/A
CapitalizationN/A
RRMGX vs SPYGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RRMGX vs. SPYGX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RRMGX is a Hold and SPYGX is a Hold.

FUNDAMENTALS
Fundamentals
RRMGX has more cash in the bank: 31.4B vs. SPYGX (1.01B). RRMGX (0.00) and SPYGX (0.00) have matching dividends . RRMGX was incepted earlier than SPYGX: RRMGX (22 years) vs SPYGX (7 years). SPYGX is a more actively managed with annual turnover of: 63.00 vs. RRMGX (21.70). RRMGX has a lower initial minimum investment than SPYGX: RRMGX (2500) vs SPYGX (100000). SPYGX annual gain was more profitable for investors over the last year : 45.96 vs. RRMGX (-1.43). SPYGX return over 5 years is better than : 50.71 vs. RRMGX (-0.88).
RRMGXSPYGXRRMGX / SPYGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years7 years-
Gain YTD-1.90646.561-4%
Front LoadN/AN/A-
Min. Initial Investment25001000003%
Min. Initial Investment IRAN/AN/A-
Net Assets31.4B1.01B3,106%
Annual Yield % from dividends0.000.00-
Returns for 1 year-1.4345.96-3%
Returns for 3 years-14.9523.54-64%
Returns for 5 years-0.8850.71-2%
Returns for 10 years21.64N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PRPH0.69N/A
N/A
ProPhase Labs
OCTO1.58N/A
N/A
Eightco Holdings Inc
AMN23.52-0.95
-3.88%
AMN Healthcare Services
PHAT7.99-0.38
-4.54%
Phathom Pharmaceuticals
U22.34-2.32
-9.41%
Unity Software